查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363168

上游生物加工市场规模、份额、趋势分析报告：按产品、工作流程、使用类型、模式、地区和细分市场进行预测，2023-2030 年

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

上游生物加工市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计2023年至2030年全球上游生物加工市场规模将以16.6%的年复合成长率成长，2030年达到591亿美元。

生物製药的商业性成功和广泛接受为一些自家公司和合约製造生物製药公司提供了一条利润丰厚的成长道路。此外，对生物相似药和生技药品的高需求、推出具有成本效益的改进技术以及一次性系统的接受度提高等要素正在共同推动市场收益。

新兴企业和新参与企业在新安装的生物製造工厂时经常面临预算限制。因此，这些营业单位正在透过将製造流程委託给合约服务来扩大其生物治疗产品组合，有助于增加上游生物加工服务的收益。

连续的上游生物加工为生物加工产业带来了显着的效益。对于生物反应器培养物的澄清，越来越多地引入声波技术和连续离心等方法，这往往会最大限度地减少澄清的负担。这导致更高的细胞培养密度和更有效率的上游工程。

细胞株生产力在蛋白质表现和克隆筛选方面的持续进步预计将在预测期内实现细胞培养产品最快的年复合成长率。细胞培养被认为是上游生物加工中最困难和关键的步骤，因此需要更多地关注技术复杂性，从而在上游生物加工市场中占据最大份额。

多用途系统等要素在于，这些系统需要一次性投资，利用率高，可应用于更大容量的生物过程，并能准确维持pH和氧气。然而，从传统不銹钢生物反应器到一次性生物反应器系统的范式转变一直是一次性领域利润丰厚成长的要素。

主要市场参与者正在采取新产品开发、互利合作伙伴关係、协议和地理扩张等策略性倡议，以加强其在市场上的影响力。例如，2019年2月，丹纳赫公司达成协议，收购通用电气生命科学公司的生物製药业务。透过此次收购，丹纳赫将 GE BioPharma 的细胞培养基、一次性技术、开发设备和消耗品添加到其现有产品组合中，扩大了其市场份额。

上游生物加工市场报告亮点

  • 生物反应器的高可用性以及主要参与者不断推出一次性生物反应器正在为生物反应器领域要素显着的收益占有率。
  • 拥有内部生物製造能力的成熟生物製药製造公司的存在导致了该领域最大的收益占有率。
  • 由于 CMO 透过将一次性系统整合到工厂来增加投资和扩大製造能力，预计上游生物加工的外包模式将在预测期内实现最快的年复合成长率。
  • 由于生物技术的不断创新和对生物製药的日益偏好，北美在全球上游生物加工市场中占据主导地位。此外，大量的内部生物製药製造商和对美国生物製药市场的大量投资也支持了成长。
  • 由于人们对可用于上游工作流程中进程内控制的快速分析方法的认识不断增强，预计亚太地区在预测期内将实现最快的年复合成长率。

目录

第1章调查方法与范围

第2章执行摘要

第3章上游生物加工市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 上游生物加工市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章上游生物製程：产品估算与趋势分析

  • 上游生物加工市场：要点
  • 上游生物加工市场：2022 年和 2030 年趋势和市场占有率分析
  • 生物反应器/发酵罐
    • 2018年至2030年生物反应器/发酵槽市场估计与预测
  • 细胞培养产品
    • 2018年至2030年细胞培养产品市场估计与预测
  • 筛选
    • 过滤 2018 年至 2030 年市场估计与预测
  • 生物反应器配件
    • 2018年至2030年生物反应器配件市场估计与预测
  • 袋子/容器
    • 2018年至2030年袋子和容器市场估计和预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第5章上游生物製程：工作流程估计与趋势分析

  • 上游生物加工市场：要点
  • 上游生物加工市场：2022 年和 2030 年趋势和市场占有率分析
  • 媒体准备
  • 细胞培养
  • 细胞分离

第6章上游生物製程：使用类型估计与趋势分析

  • 上游生物加工市场：要点
  • 上游生物加工市场：2022 年和 2030 年趋势和市场占有率分析
  • 用途的
    • 2018年至2030年用途市场估计与预测
  • 一次使用
    • 2018年至2030年一次性市场估计与预测

第7章上游生物过程：模式估计/趋势分析

  • 上游生物加工市场：要点
  • 上游生物加工市场：2022 年和 2030 年趋势和市场占有率分析
  • 公司内部
  • 委託

第8章上游生物製程市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的上游生物加工市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • GE HealthCare
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Corning, Inc.
    • Sartorius AG
    • Eppendorf AG
    • Danaher
    • Boehringer Ingelheim GmbH
    • Applikon Biotechnology
    • PBS Biotech, Inc.
    • Lonza
    • CellGenix GmbH
    • Samsung BioLogics
    • AGC Inc.
    • VWR International, LLC
Product Code: GVR-3-68038-592-2

Upstream Bioprocessing Market Growth & Trends:

The global upstream bioprocessing market size is expected to reach USD 59.1 billion by 2030, expanding at a CAGR of 16.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights:

  • High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
  • Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
  • Outsourced mode of upstream bioprocessing is anticipated to witness the fastest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
  • North America dominated the global upstream bioprocessing market as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
  • Asia Pacific is poised to witness the fastest CAGR over the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Workflow
    • 1.1.3. Use Type
    • 1.1.4. Mode
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Workflow outlook
    • 2.2.3. Use type outlook
    • 2.2.4. Mode outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Upstream Bioprocessing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Upstream Bioprocessing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Upstream Bioprocessing: Product Estimates & Trend Analysis

  • 4.1. Upstream Bioprocessing Market: Key Takeaways
  • 4.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bioreactors/Fermenters
    • 4.3.1. Bioreactors/Fermenters market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Cell Culture Products
    • 4.4.1. Cell culture products market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Filters
    • 4.5.1. Filters market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Bioreactors Accessories
    • 4.6.1. Bioreactors accessories market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.7. Bags & Containers
    • 4.7.1. Bags & containers market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Upstream Bioprocessing: Workflow Estimates & Trend Analysis

  • 5.1. Upstream Bioprocessing Market: Key Takeaways
  • 5.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Media Preparation
    • 5.3.1. Media preparation market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. Cell Culture
    • 5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Cell Separation
    • 5.5.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Upstream Bioprocessing: Use Type Estimates & Trend Analysis

  • 6.1. Upstream Bioprocessing Market: Key Takeaways
  • 6.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Multi-Use
    • 6.3.1. Multi-use market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.4. Single-Use
    • 6.4.1. Single-use market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Upstream Bioprocessing: Mode Estimates & Trend Analysis

  • 7.1. Upstream Bioprocessing Market: Key Takeaways
  • 7.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. In-House
    • 7.3.1. In-house market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 7.4. Outsourced
    • 7.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Upstream Bioprocessing Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Market Participant Categorization
    • 9.2.1. GE HealthCare
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Thermo Fisher Scientific Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Merck KGaA
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Corning, Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Sartorius AG
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Eppendorf AG
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Danaher
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Boehringer Ingelheim GmbH
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Applikon Biotechnology
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. PBS Biotech, Inc.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Lonza
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. CellGenix GmbH
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Samsung BioLogics
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. AGC Inc.
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Product benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. VWR International, LLC
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Product benchmarking
      • 9.2.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 3 North America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 4 North America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 5 North America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 6 North America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 7 U.S. upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 8 U.S. upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 9 U.S. upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 10 U.S. upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 11 Canada upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 12 Canada upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 13 Canada upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 14 Canada upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 15 Europe upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 16 Europe upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 17 Europe upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 18 Europe upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 19 Europe upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 20 Germany upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 21 Germany upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 22 Germany upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 23 Germany upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 24 UK upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 25 UK upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 26 UK upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 27 UK upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 28 France upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 29 France upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 30 France upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 31 France upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 32 Italy upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 33 Italy upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 34 Italy upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 35 Italy upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 36 Spain upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 37 Spain upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 38 Spain upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 39 Spain upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 40 Sweden upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 41 Sweden upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 42 Sweden upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 43 Sweden upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 44 Norway upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 45 Norway upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 46 Norway upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 47 Norway upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 48 Denmark upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 49 Denmark upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 50 Denmark upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 51 Denmark upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 54 Asia Pacific upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 55 Asia Pacific upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 56 Asia Pacific upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 57 Japan upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 58 Japan upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 59 Japan upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 60 Japan upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 61 China upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 62 China upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 63 China upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 64 China upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 65 India upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 66 India upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 67 India upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 68 India upstream bioprocessing market, by mode (USD Billion) 2018 - 2030
  • Table 69 Australia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 70 Australia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 71 Australia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 72 Australia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 73 Thailand upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 74 Thailand upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 75 Thailand upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 76 Thailand upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 77 South Korea upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 78 South Korea upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 79 South Korea upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 80 South Korea upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 81 Latin America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 82 Latin America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 83 Latin America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 84 Latin America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 85 Latin America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 86 Brazil upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 87 Brazil upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 88 Brazil upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 89 Brazil upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 90 Mexico upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 91 Mexico upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 92 Mexico upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 93 Mexico upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 94 Argentina upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 95 Argentina upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 96 Argentina upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 97 Argentina upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 98 Middle East and Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 99 Middle East and Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 100 Middle East and Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 101 Middle East and Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 102 Middle East and Africa upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 103 South Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 104 South Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 105 South Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 106 South Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 107 Saudi Arabia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 108 Saudi Arabia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 109 Saudi Arabia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 110 Saudi Arabia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 111 UAE upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 112 UAE upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 113 UAE upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 114 UAE upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 115 Kuwait upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 116 Kuwait upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 117 Kuwait upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 118 Kuwait upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Upstream bioprocessing: Market outlook
  • Fig. 8 Upstream bioprocessing: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Upstream bioprocessing market driver impact
  • Fig. 14 Upstream bioprocessing market restraint impact
  • Fig. 15 Upstream bioprocessing market strategic initiatives analysis
  • Fig. 16 Upstream bioprocessing market: Product movement analysis
  • Fig. 17 Upstream bioprocessing market: Product outlook and key takeaways
  • Fig. 18 Bioreactors/Fermenters market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Cell culture products market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Filters market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Bioreactors accessories market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Bags & containers market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Upstream bioprocessing market: Workflow movement analysis
  • Fig. 25 Upstream bioprocessing market: Workflow outlook and key takeaways
  • Fig. 26 Media preparation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Cell culture market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Cell separation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Upstream bioprocessing market: Use type movement analysis (USD Billion)
  • Fig. 30 Upstream bioprocessing market: Use type outlook and key takeaways
  • Fig. 31 Multi-use market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Single-use market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Upstream bioprocessing market: Mode movement analysis
  • Fig. 34 Upstream bioprocessing market: Mode outlook and key takeaways
  • Fig. 35 In-house market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Outsourced market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Global upstream bioprocessing market: Regional movement analysis
  • Fig. 38 Global upstream bioprocessing market: Regional outlook and key takeaways
  • Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)